Press Release – New York, NY – August 31, 2026 – Sichenzia Ross Ference Carmel LLP announced that it represented D. Boral Capital as the exclusive placement agent for the recently priced $2 million registered direct offering of Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage biopharmaceutical company advancing a therapeutic pipeline targeting central nervous system disorders and neuroinflammation.
The SRFC team was led by partner Ross Carmel, with associate Jesse Blue.